awmsg logo
Home | About us | Contact us

Meeting dates and papers

15 February 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 aflibercept (Eylea)
Minutes of the previous AWPAG meeting
National Prescribing Indicators 2016-2017 - Analysis of Prescribing Data to September 2016
National Prescribing Indicators 2017-2018
National Prescribing Indicators 2017-2018 - Supporting Information for Prescribers
Appraisal 2 human alpha1-proteinase inhibitor (Respreeza)
Appraisal 3 triptorelin (Decapeptyl SR)
Medicines Management Resource for Chronic Kidney Disease
CEPP National Audit - Medicines Management for Chronic Kidney Disease

15 March 2017 |


The Angel Hotel, Abergavenny

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 ivacaftor (Kalydeco)
Appraisal 2 bevacizumab (Avastin)
Appraisal 3 idelalisib (Zydelig)

26 April 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 emtricitabine/tenofovir disoproxil fumarate (Truvada)
Appraisal 2 vismodegib (Erivedge)
Feedback from AWPAG Meeting held 1 March 2017

21 June 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 ivacaftor (Kalydeco)
NPIs 2016-2017 Analysis of Prescribing Data to December 2016
All Wales Multidisciplinary Medicines Reconciliation Policy
Appraisal 2 aviptadil phentolamine (Invicorp)

19 July 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 adalimumab (Humira)
Appraisal 2 desmopressin lyophilisate (Noqdirna)
Appraisal 3 cefuroxime (Aprokam)
Appraisal 4 triamcinolone hexacetonide (none)

13 September 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 desmopressin lyophilisate (Noqdirna)
Appraisal 2 afamelanotide (Scenesse)
Minutes of the previous AWPAG meeting
Medicines identified as low priority for funding in NHS Wales
National Prescribing Indicators 2016-2017: Analysis of Prescribing Data to March 2017

11 October 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 lenvatinib (Lenvima)
Appraisal 2 glecaprevir/pibrentasvir (Maviret)
Appraisal 3 dolutegravir (Tivicay)
Appraisal 4 c1 inhibitor (Cinryze)
Appraisal 5 5-aminolaevulinic acid (Ameluz)
Appraisal 6 tiotropium (Spiriva Respimat)
Medicines identified as low priority for funding in NHS Wales

8 November 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 pegvisomant (Somavert)
Appraisal 2 levodopa-carbidopa intestinal gel (Duodopa)
Appraisal 3 stiripentol (Diacomit)

6 December 2017 |


Park Inn, Cardiff North

Meeting papers
available

Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 adalimumab (Humira)
AWMSG Five Year Strategy 2018–2023
National Prescribing Indicators 2017–2018 – Analysis of Prescribing Data to June 2017
Yellow Card Centre Wales – Five year report
Feedback from AWPAG meeting held 27 September 2017